Literature DB >> 1098458

Cardiac amyloidosis. Diagnosis by transvenous endomyocardial biopsy.

J S Schroeder, M E Billingham, A K Rider.   

Abstract

Endomyocardial tissue, obtained from two patients presenting with restrictive cardiomyopathies, demonstrated amyloid infiltration. The percutaneous transvenous cardiac biopsy technic, using a modified Konno-Sakakibara cardiac bioptome, was safe and quick. Physical examination and catheterization data may not provide a definite differential diagnosis between restrictive and constrictive myocardial disease. Confirmation by biopsy of the cardiac amyloidosis assisted in providing optimum diagnostic and therapeutic care for these patients.

Entities:  

Mesh:

Year:  1975        PMID: 1098458     DOI: 10.1016/0002-9343(75)90362-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden.

Authors:  A Eriksson; P Eriksson; B O Olofsson; L E Thornell
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

2.  Usefulness of endomyocardial biopsy in tertiary care.

Authors:  J D Hosenpud
Journal:  West J Med       Date:  1989-01

3.  Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.

Authors:  P Eriksson; C Backman; P Bjerle; A Eriksson; S Holm; B O Olofsson
Journal:  Br Heart J       Date:  1984-09

4.  Manifestation and ultrastructural typing of amyloid deposits in the heart.

Authors:  S Störkel; H M Schneider; W Thoenes
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

5.  Cardiac amyloidosis diagnosed by endomyocardial biopsy.

Authors:  M A Kim; C H Kim; B H Oh; Y B Park; Y S Choi; J D Seo; Y W Lee
Journal:  Korean J Intern Med       Date:  1988-07       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.